153 related articles for article (PubMed ID: 17666793)
1. Irinotecan-induced apoptosis is inhibited by increased P-glycoprotein expression and decreased p53 in human hepatocellular carcinoma cells.
Takeba Y; Sekine S; Kumai T; Matsumoto N; Nakaya S; Tsuzuki Y; Yanagida Y; Nakano H; Asakura T; Ohtsubo T; Kobayashi S
Biol Pharm Bull; 2007 Aug; 30(8):1400-6. PubMed ID: 17666793
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis.
Takeba Y; Kumai T; Matsumoto N; Nakaya S; Tsuzuki Y; Yanagida Y; Kobayashi S
J Pharmacol Sci; 2007 Jul; 104(3):232-42. PubMed ID: 17609585
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells.
Zhang XW; Xu B
Anticancer Drugs; 2000 Oct; 11(9):747-56. PubMed ID: 11129738
[TBL] [Abstract][Full Text] [Related]
4. [Reversal of multidrug resistance of human hepatocellular carcinoma cells by wild-type p53 gene and related mechanisms].
Gai XD; Li GL; Huang JZ; Xue HJ; Wang D
Ai Zheng; 2006 Aug; 25(8):954-9. PubMed ID: 16965674
[TBL] [Abstract][Full Text] [Related]
5. CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated protein.
Jansen WJ; Hulscher TM; van Ark-Otte J; Giaccone G; Pinedo HM; Boven E
Br J Cancer; 1998; 77(3):359-65. PubMed ID: 9472629
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitivity determinants of irinotecan hydrochloride in hepatocellular carcinoma cell lines.
Takahata T; Ookawa K; Suto K; Tanaka M; Yano H; Nakashima O; Kojiro M; Tamura Y; Tateishi T; Sakata Y; Fukuda S
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):399-407. PubMed ID: 18248513
[TBL] [Abstract][Full Text] [Related]
7. DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosis.
Bhonde MR; Hanski ML; Budczies J; Cao M; Gillissen B; Moorthy D; Simonetta F; Scherübl H; Truss M; Hagemeier C; Mewes HW; Daniel PT; Zeitz M; Hanski C
J Biol Chem; 2006 Mar; 281(13):8675-85. PubMed ID: 16446370
[TBL] [Abstract][Full Text] [Related]
8. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
McDonald AC; Brown R
Br J Cancer; 1998 Sep; 78(6):745-51. PubMed ID: 9743293
[TBL] [Abstract][Full Text] [Related]
9. The interactive transcript abundance index [c-myc*p73alpha]/[p21*Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines.
Harr MW; Willey JC
Int J Oncol; 2007 Jun; 30(6):1553-60. PubMed ID: 17487378
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.
Dai XY; Zhuang LH; Wang DD; Zhou TY; Chang LL; Gai RH; Zhu DF; Yang B; Zhu H; He QJ
Oncotarget; 2016 Feb; 7(6):6933-47. PubMed ID: 26771844
[TBL] [Abstract][Full Text] [Related]
11. Factors contributing to the resistance to apoptosis induced by topoisomerase I inhibitors in vincristine resistant cells.
Palissot V; Trussardi A; Gorisse MC; Dufer J
Adv Exp Med Biol; 1999; 457():355-63. PubMed ID: 10500811
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary.
Itamochi H; Kigawa J; Sultana H; Iba T; Akeshima R; Kamazawa S; Kanamori Y; Terakawa N
Jpn J Cancer Res; 2002 Jun; 93(6):723-8. PubMed ID: 12079522
[TBL] [Abstract][Full Text] [Related]
13. SN-38 induces cell cycle arrest and apoptosis in human testicular cancer.
Ueno M; Nonaka S; Yamazaki R; Deguchi N; Murai M
Eur Urol; 2002 Oct; 42(4):390-7. PubMed ID: 12361906
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
Chen TC; Su S; Fry D; Liebes L
Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
[TBL] [Abstract][Full Text] [Related]
15. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
Crea F; Giovannetti E; Cortesi F; Mey V; Nannizzi S; Gallegos Ruiz MI; Ricciardi S; Del Tacca M; Peters GJ; Danesi R
Mol Cancer Ther; 2009 Jul; 8(7):1964-73. PubMed ID: 19531575
[TBL] [Abstract][Full Text] [Related]
17. Role of p53 in irinotecan-induced intestinal cell death and mucosal damage.
Bowen JM; Gibson RJ; Stringer AM; Chan TW; Prabowo AS; Cummins AG; Keefe DM
Anticancer Drugs; 2007 Feb; 18(2):197-210. PubMed ID: 17159606
[TBL] [Abstract][Full Text] [Related]
18. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
[TBL] [Abstract][Full Text] [Related]
19. Loss of one allele of the p53 gene in the lens epithelial tumor in transgenic mice suppresses apoptosis induced by a topoisomerase I inhibitor (CPT-11).
Nakajima Y; Nakamura T; Enomoto T; Murata Y
Cancer Lett; 2002 May; 179(2):165-73. PubMed ID: 11888671
[TBL] [Abstract][Full Text] [Related]
20. [Cinnamaldehyde ofloxacin-3-ylhydrazone induces apoptosis of human hepatocarcinoma SMMC-7721 cells].
Ren Z; Kang YH; Shi ZY; Huang-Fu CS; Hu GQ; Liu B
Yao Xue Xue Bao; 2010 Sep; 45(9):1109-15. PubMed ID: 21351566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
